Silvia Lucano-Landeros

Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies

Arturo Santos, J. Armendáriz-Borunda, S. Lucano-Landeros, 2022, Cancers.

Roles of Nrf2 in Liver Diseases: Molecular, Pharmacological, and Epigenetic Aspects

Arturo Santos, J. Armendáriz-Borunda, J. Silva-Gomez, 2020, Antioxidants.

Pirfenidone Accelerates Wound Healing in Chronic Diabetic Foot Ulcers: A Randomized, Double-Blind Controlled Trial

A. Santos-García, J. Armendáriz-Borunda, J. Domínguez-Rosales, 2017, Journal of diabetes research.

Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C

J. Armendáriz-Borunda, A. Sandoval-Rodríguez, S. Lucano-Landeros, 2014, BMC Gastroenterology.

Role and New Insights of Pirfenidone in Fibrotic Diseases

J. Armendáriz-Borunda, S. Sánchez-Enríquez, S. Lucano-Landeros, 2015, International journal of medical sciences.

Liver Cancer: Therapeutic Challenges and the Importance of Experimental Models

Arturo Santos, J. Armendáriz-Borunda, J. Silva-Gomez, 2021, Canadian journal of gastroenterology & hepatology.

Evaluation of Safety of a Newly Formulated Pirfenidone in Chronic Kidney Disease: A Non-Randomized Pilot Study in Mexican Patients

Arturo Santos, J. Armendáriz-Borunda, A. Sandoval-Rodríguez, 2020 .

Pirfenidone Protects from UVB-Induced Photodamage in Hairless Mice

Arturo Santos, J. Armendáriz-Borunda, M. Galicia-Moreno, 2023, Molecules.